A
Absci
Vancouver, United States
Founded 2011 NASDAQ: ABSI
About
Generative AI drug creation company designing and validating novel biologic drugs
Company Details
- Type
- public
- Employees
- 200+
- Funding
- Public
Key Products
- Integrated Drug Creation Platform
- SoluPro
- ACE Assay